On the Cover
Laser treatment in children October 03, 2017By Karen AppoldLaser treatments can have a significant positive impact on a child’s wellbeing. Adopt techniques to minimize anxiety for children. Some conditions can be treated when the child is older.
In this issue
The weightless word challenge September 27, 2017By Elaine Siegfried M.D.There is no doubt that living with distinguishing physical features can be difficult. More than one study has ranked chronic skin disease as a condition with the greatest negative impact on a child’s quality of life. The expert words of medical providers can have a significant impact on these essential concerns. I prescribe compounded medications. Can I be sued?Dr. Skin has a large dermatology practice and treats a variety of medical and cosmetic conditions. He has studied and lectured extensively on the topic of rosacea. He understands much of the pathophysiology of rosacea. He begins to use a copycat version of a compounded topical, which he has been able to get at a discounted rate. Unfortunately several patients have severe reactions, and he is soon the recipient of multiple medical malpractice lawsuits. Has he done anything wrong?
Practice gaps in childhood acne treatment February 16, 2017By Bob KronemyerCombination therapies are under used; the role of diet, while controversial, may be beneficial; and, cosmeceuticals may remedy mild-to-moderate acne. Read more on acne treatment guidelines. Dermatologists collaborate on data-driven pediatric psoriasis research August 08, 2017By Lisette HiltonA global community of physicians cooperated to share experiences with systemic drugs for pediatric psoriasis, and to get experience with a joint registry. A uniform dataset could be tapped to learn more about disease manifestations and treatment outcomes Gene therapy trial for blistering skin condition advancing to next stage August 31, 2017By Lisette HiltonFCX-007 could be the first major medical advance for recessive dystrophic epidermolysis bullosa, or RDEB, in decades.
Atopic dermatitis associated with different bacteria depending on disease severity September 07, 2017By Andrew BowserNIH investigators find that Staphylococcus epidermidis is predominant in less severe cases, while Staphylococcus aureus is associated with patients who have more severe disease. Patch testing remains underreported October 03, 2017By Bob KronemyerPatch testing for allergic contact dermatitis in the pediatric population is performed at a higher rate than previously reported, but still grossly underreported, according to a study of the Pediatric Contact Dermatitis Registry. Propranolol equal to steroids in infantile hemangioma treatment October 03, 2017By Bob KronemyerPrednisolone was the first-line therapy for hemangiomas for many years before propranolol was recognized as the treatment of choice in infantile hemangiomas. Both modalities have a 90% response rate. The neonatal microbiome October 03, 2017By Lisette HiltonCesarean section newborns have a slightly delayed microbiome response. The richness of microorganisms is less than vaginally delivered newborns by 3-7 days. Use products on neonatal skin that are designed for neonatal skin.
Data support panfacial aesthetics approach October 04, 2017By John JesitusThe HARMONY study puts objective data behind the aesthetic and psychological improvements delivered by a panfacial approach to facial rejuvenation. It’s also the first study to use video analysis, and online photo ratings from a representative sample of Americans, as outcome measures. Proven steps to enhance the aesthetic consult October 04, 2017By Lisette HiltonThe consult can make or break your success. Listen to and question concerns. Show you care. The concerns around phthalatesOne of the most concerning group of chemicals are phthalates, which are used as plasticizers to increase the flexibility, transparency, durability and longevity of plastics Health concerns with BPABPA is found in food containers, dental fillings and vitamin gel capsules. It also is found in milk, butter and meats, just like phthalates, and is also considered a hormone disruptor.
The many faces of melanoma August 15, 2017By Ilya Petrou M.DBeginning this week, we will publish a series of case studies and quizzes on the subtypes and features of melanoma. Case study: 20 non-melanomas and now this mysterious lesionIn this case, the clinical diagnosis can be difficult as the features of the lesion overlap in this 90-year-old patient. What is the diagnosis? Superficial spreading in lentigo malignaA 61-year-old white female with a past medical history of atrial fibrillation presents with a brown spot on her right ear of unknown duration. What wouldn’t you do during the first office visit? Melanoma quiz: Diagnosis, differential and black patches71-year-old Caucasian woman presents with an asymptomatic 4 cm x 2.5 cm black patch. Case presentation: Subungual melanomaA Caucasian female presented with a dark brown band on her nail that appeared a few years ago signifying subungual melanoma. What is the most concerning symptom? Quiz: Acral lentiginous melanomaIn this installment of our melanoma case studies series, we focus on factors associated with acral lentiginous melanoma. FDA expands ipilimumab approval to pediatric melanoma
July 25, 2017The US Food and Drug Administration (FDA) has expanded the approval of ipilimumab (Yervoy) to include the treatment of pediatric melanoma patients 12 years and older with unresectable or metastatic disease.
Changing moles in teens October 04, 2017By Bob KronemyerMole count in adolescents predictor of melanoma. Sun exposure habits develop in teen years. Prevent melanoma through sun protection. Reduce the number of unnecessary biopsies.
Table of the Month
Considerations for laser treatment in pediatric patients
November 06, 2017From psychosocial considerations to pain control, in pediatrics, there are a special set of factors physicians should consider before treating these young patients. Reference our table for insights.
Sonidegib gets a new label for recurring laBCC October 01, 2017By Sarah ThuerkSun Pharmaceutical Industries announced in September the FDA has approved a new label for sonidegib (Odomzo, Novartis), an oral hedgehog inhibitor indicated for the treatment of adults with locally advanced basal cell carcinoma (laBCC) that has recurred following surgery or radiation therapy, or for patients who are not candidates for surgery or radiation therapy.